Company Email Format Management

Cogent Biosciences

Biotechnology Research 275 Wyman Street 234 employees

Employees: 234
Contacts: 4
Emails: 4
Phones: 3

cogentbio.com LinkedIn Crunchbase

Cogent Biosciences Overview

Headquarters: 275 Wyman Street
Phone Number: Available in AeroLeads
Website: cogentbio.com
Industry: Biotechnology Research
Employees: 234
Founded: 2014
Funding: 230.0M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

gastrointestinal stromal tumors (GIST) Oncology Systemic Mastocytosis kinase inhibitors

About Cogent Biosciences

Cogent Biosciences is a biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet medical needs. Cogent’s lead program, bezuclastinib, is designed to selectively and potently inhibit exon 17 mutations found within the KIT receptor tyrosine kinase, including KIT D816V. KIT D816V is responsible for driving a rare and serious condition called Systemic Mastocytosis, and exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Bezuclastinib has already exhibited promising early clinical activity and safety in a Phase 1/2 trial in patients with advanced GIST and also has the potential to fill an unmet need for patients living with Systemic Mastocytosis.

Cogent Biosciences Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 3; 75.0% coverage

Cogent Biosciences Org Chart

Sample employees and titles

Name	Title	Location	Contact
Bryan Grace		Boulder, Colorado, United States	Email
Todd Shegog	Board Member at Cogent Biosciences	Winchester, Massachusetts, United States	Email Phone
Sasha Zbitnoff	Biotech Program Manager	Haverhill, Massachusetts, United States	Email Phone
Brad Barnett		Boulder, Colorado, United States	Email Phone